Award notice, first published as presolicitation
Strategic Marburg Advanced Research and Development, Preparedness, Registration, Evaluation and Procurement (SMART-PREP)
75A50125R00006
Office of Assistant Secretary for Preparedness and Response, Barda - Aspr / Daappo / Barda DCMA. Research and Development in Biotechnology (except Nanobiotechnology).
Awarded
Albert B. Sabin Vaccine Institute, Inc. (The)
$1,042,099,118.00 on the award notice, May 5, 2026, contract 75A50126C00001
Get the next one like this from Office of Assistant Secretary for Preparedness and Response by email, the day it is posted.Find my opportunities
This one was awarded in 2025
18 like it are open now in research and development in biotechnology (except nanobiotechnology)
- Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response
Office of Assistant Secretary for Preparedness and Response, Barda - Aspr / Daappo / Barda DCMA
SolicitationNAICS 541714Washington, DC75A50126R00001_RFP_NPIVS_27Closes in 19 daysNov 20 - ARPA-H Emerging Health Innovators (EHI) Initiative
National Institutes of Health, Advanced Research Projects Agency for Health (Arpa-H)
SolicitationNAICS 541714District of ColumbiaARPA-H-SOL-26-150Closes in 101 daysFeb 10, 2027 - BROAD AGENCY ANNOUNCEMENT - BIOMEDICAL RESEARCH AND DIVING EQUIPMENT DEVELOPMENT
Department of the Navy, NAVSEA HQ
SolicitationNAICS 541714District of ColumbiaN0002427S0001Closes in 394 daysNov 30, 2027
All 18 open in research and development in biotechnology (except nanobiotechnology)
Description
As published on SAM.gov.
This acquisition will allow BARDA to invest Project BioShield funds for the advanced development, US Food and Drug Administration (FDA) licensure, procurement, shipping, and vendor managed inventory (VMI) storage of MARV monovalent vaccine.
This contract was awarded on a hybrid cost reiumbursement/fixed price basis as circumstances do not allow the agency to define its requirements sufficiently to allow for a fixed-price type contract.
The contract, on USAspending
Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.
- UEI
- H5E8NU6N2HZ5
- CAGE
- 5MPW2
- Vendor location
- Washington, DC
- Contract
- 75A50126C00001, definitive contract
- Obligated
- $263,613,186.00, potential $1,042,099,118
- Actions
- 2 between May 5, 2026 and August 19, 2026
- Competition
- Full and Open Competition, 1 offer received
- Set-aside reported
- No Set Aside Used.
- Described as
- Strategic Marburg Advanced Research and Development, Preparedness, Registration, Evaluation and Procurement (Smart-Prep)
- Match
- award number 75A50126C00001 equals the contract number; same awarding office 75A501 (high confidence)
- Record
- USAspending award page
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
June 27, 2025
Presolicitation
Marburg virus (MARV) and Sudan virus (SUDV) Vaccines
Due July 11, 2025 at 12:00 PM EDT. SAM.gov, notice 66553ff7754346dca558f3e8719cb32b
July 13, 2025
Solicitation, originally presolicitation
Marburg virus (MARV) and Sudan virus (SUDV) Vaccines
Due August 26, 2025 at 2:00 PM EDT. SAM.gov, notice 1245b97261a248c098f549dc050eb35a
July 14, 2025
Solicitation
Marburg virus (MARV) and Sudan virus (SUDV) Vaccines
Due August 26, 2025 at 2:00 PM EDT. SAM.gov, notice fb1420f8176f4a6b89f7a21fb7569726
July 31, 2025
Solicitation
Marburg virus (MARV) and Sudan virus (SUDV) Vaccines
Due August 27, 2025 at 2:00 PM EDT. SAM.gov, notice fba2112d7da54dc49033b9adbe509953
May 7, 2026
Award notice
Awarded to Albert B. Sabin Vaccine Institute, Inc. (The) for $1,042,099,118. SAM.gov, notice 3df48ade7cef4a8482cc8139deab5e1c
1 revisions on SAM
- May 7, 2026: publish, award notice
Points of contact
- Yifan Yangyifan.yang@hhs.gov
- Greg Smithgreg.smith1@hhs.gov